Trial Profile
Phase II trial of oxaliplatin in combination with bolus/infusional 5FU/LV (FOLFOX4) in patients with advanced gastrointestinal (GI) cancers with varying degrees of renal impairment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2008
Price :
$35
*
At a glance
- Drugs Oxaliplatin (Primary) ; Fluorouracil; Folinic acid
- Indications Gastrointestinal cancer
- Focus Therapeutic Use
- 09 Dec 2008 End date identified from clinicaltrials.gov.
- 20 Aug 2008 Actual number of patients added (source ClinicalTrials.gov).
- 20 Aug 2008 Primary endpoint added to ClinicalTrials.gov.